Shares of Veradigm Inc. (NASDAQ:MDRX – Get Free Report) have received an average recommendation of “Hold” from the five ratings firms that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $12.00.
Separately, StockNews.com began coverage on Veradigm in a report on Tuesday. They set a “hold” rating on the stock.
Get Our Latest Research Report on Veradigm
Institutional Inflows and Outflows
Veradigm Stock Performance
MDRX stock opened at $9.50 on Friday. Veradigm has a 52-week low of $5.01 and a 52-week high of $14.09. The stock’s 50 day moving average is $9.60 and its two-hundred day moving average is $9.01.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- What is a Dividend King?
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- Insider Trading – What You Need to Know
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.